Senior insider sale
Chief Medical Officer at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$626.6K
16.97K shares
What this filing means
INRIG JULA plans to sell 16.97K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $626.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/15/2026ACC: 0001950047-26-003477
Officer· Chief Medical Officer
Since Jan 2022
16.97K
Shares to sell
$626.6K
Approx. market value
1.02K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Performance Shares
Not Applicable
4/13/2026
1.02KTotal acquired1.02K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/13/2026 | Performance Shares Not Applicable | 1.02K | — |
| Total | 1.02K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
7.21K
Market value
$302.5K
4/14/2026
—Completed
Units to sell
1.78K
Market value
$57.3K
2/4/2026
—Completed
Units to sell
6.96K
Market value
$223.4K
2/3/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.02K
Market value
$43.4K
4/15/2026
Total
Units
16.97K
Value
$626.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/14/2026 | 7.21K | $302.5K | — | Completed |
2/4/2026 | 1.78K | $57.3K | — | Completed |
2/3/2026 | 6.96K | $223.4K | — | Completed |
| Planned — Approximate Date | ||||
4/15/2026 | 1.02K | $43.4K | NASDAQ | Planned |
| Total | 16.97K | $626.6K | ||